- Global Pharma News & Resources

The Statin Market will register a CAGR of over 2% by 2023

The Statin Market will register a CAGR of over 2% by 2023

PR Newswire

NEW YORK, Dec. 3, 2018

NEW YORK, Dec. 3, 2018 /PRNewswire/ -- 129 pages, October 2018

About this market
The increasing statin use will help the market grow at a steady rate. In the US and the UK, people aged 40 and above are recommended to monitor their cholesterol level. Statins are considered an evidence-based treatment for high risk patients with elevated cardiovascular disorder. Technavio's analysts have predicted that the statin market will register a CAGR of over 2% by 2023.

Read the full report:

Market Overview
Rising prevalence of hypercholesterolemia
The rising prevalence of hypercholesterolemia is fueling the demand for generic cholesterol medications. Cardiovascular disease is one of the primary causes of mortality in Western countries.
Fierce generic competition
Patient expiration is a major challenge for companies developing branded drugs as it provides an opportunity for the development of generic drugs.
For the detailed list of factors that will drive and challenge the growth of the statin market during the 2019-2023, view our report.

Competitive Landscape
The market appears to be fragmented and with the presence of several companies including AstraZeneca and Merck the competitive environment is quite intense. Factors such as the increasing statin use and the rising prevalence of hypercholesterolemia, will provide considerable growth opportunities to statin manufactures. AstraZeneca, Merck, Pfizer, and Novartis are some of the major companies covered in this report.

'With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies. Many established statin manufacturers are vying for their share of the global statin market, and the new players must differentiate themselves to gain vital traction over their competitors.'

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare:
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:

SOURCE Reportlinker

Editor Details

Last Updated: 03-Dec-2018